Obstructive sleep apnoea: Mandibular advancement device helps against daytime sleepiness

June 03, 2020

With the help of a mandibular advancement device (MAD), daytime sleepiness of patients with obstructive sleep apnoea can be relieved. Treatment with an MAD is not inferior to positive airway pressure (PAP) therapy with a sleep mask. This is the conclusion reached by the German Institute for Quality and Efficiency in Health Care (IQWiG) in its final report on the benefit of MAD.

Breathing pauses disturb sleep and lead to daytime sleepiness

Obstructive sleep apnoea is characterized by a recurrent obstruction (= narrowing / blockage) of the upper airway during sleep. It occurs when the upper airway muscles become flaccid. This narrows the airway in the pharynx or even blocks it completely, resulting in loud snoring sounds when breathing in and out. People with obstructive sleep apnoea - usually without noticing it - have difficulties breathing while sleeping, including breathing pauses, and are very sleepy during the day. In the long term, this increases the risk of other diseases and can have a huge impact on quality of life. It is estimated that about 5% of men and 3% of women suffer from obstructive sleep apnoea.

A mandibular advancement device keeps the airways open mechanically

The treatment of obstructive sleep apnoea depends on the severity of the disease. If it is mild, conservative measures such as weight reduction, sleep hygiene measures (no alcohol, no smoking) or positional therapy (avoiding lying on the back while sleeping) can alleviate the symptoms. For a higher degree of severity, PAP therapy with a sleep mask is used as standard treatment, where ventilation with positive pressure is used to keep the patients' airways open.

According to the relevant clinical practice guideline, mild to moderate obstructive sleep apnoea can also be treated with an MAD. The plastic splint in the mouth, fitted by a dentist or orthodontist, then ensures that the lower jaw is held further forward, keeping the upper airway mechanically open. This method is usually well tolerated and is in many cases preferred by patients over PAP therapy. However, MAD treatment is not suitable for all patients: In cases of toothlessness, insufficient remaining teeth or pronounced periodontitis, for example, the plastic splint cannot be worn.

Treatment with an MAD is not inferior to PAP therapy

On behalf of the Federal Joint Committee (G-BA), IQWiG investigated in 2 research questions whether wearing an MAD is beneficial for obstructive sleep apnoea:

In comparison to no treatment or treatment with a placebo splint (research question 1), IQWiG researchers infer an indication of a benefit of wearing an MAD for the patient-relevant outcome "daytime sleepiness". This benefit is not challenged by the results on other patient-relevant outcomes (including sleep quality, cognitive performance, depressive symptoms and headaches). No data were available for the outcomes of overall mortality or survival and cardiovascular morbidity. In comparison with PAP therapy (research question 2), the IQWiG researchers infer an indication of non-inferiority of MAD versus PAP therapy for the patient-relevant outcome "daytime sleepiness". With regard to other patient-relevant outcomes, there was no disadvantage of MAD compared with PAP therapy either. No usable data were available for the outcomes of overall mortality or survival and cardiovascular morbidity.

The conclusions on the benefit of MAD are based on the results of 18 randomized controlled trials (RCTs) included in the assessment. To investigate the non-inferiority of MAD, the IQWiG project team was able to use the results from 17 RCTs. Many of the studies did not differentiate according to the severity of obstructive sleep apnoea, but included all persons with obstructive sleep apnoea or summarized several degrees of severity. This includes persons with mild to moderate obstructive sleep apnoea, who, according to the G-BA's commission, should be the focus of the benefit assessment.

After the hearing: "hint" becomes "indication"

In comparison with the preliminary report, the IQWiG project team upgraded the conclusions on the benefit of MAD from "hint" to "indication", both in comparison with no treatment or placebo (research question 1) and for the non-inferiority of MAD versus PAP therapy (research question 2). This also happened because, in the context of the hearing on the preliminary report, the participants submitting comments pointed out calculation errors in the probability calculations, which IQWiG has now corrected. Among other things, this resulted in different correlation coefficients for the assessments. In addition, a new study also provided additional evidence for research question 2 (MAD vs. PAP therapy). This led to more robust assessment results for both research questions regarding the outcome "daytime sleepiness".

An English extract of this report will be available soon. If you would like to be informed when it is published, please contact info@iqwig.de
-end-


Institute for Quality and Efficiency in Health Care

Related Sleep Articles from Brightsurf:

Size and sleep: New research reveals why little things sleep longer
Using data from humans and other mammals, a team of scientists including researchers from the Santa Fe Institute has developed one of the first quantitative models that explains why sleep times across species and during development decrease as brains get bigger.

Wind turbine noise affects dream sleep and perceived sleep restoration
Wind turbine noise (WTN) influences people's perception of the restorative effects of sleep, and also has a small but significant effect on dream sleep, otherwise known as REM (rapid eye movement) sleep, a study at the University of Gothenburg, Sweden, shows.

To sleep deeply: The brainstem neurons that regulate non-REM sleep
University of Tsukuba researchers identified neurons that promote non-REM sleep in the brainstem in mice.

Chronic opioid therapy can disrupt sleep, increase risk of sleep disorders
Patients and medical providers should be aware that chronic opioid use can interfere with sleep by reducing sleep efficiency and increasing the risk of sleep-disordered breathing, according to a position statement from the American Academy of Sleep Medicine.

'Short sleep' gene prevents memory deficits associated with sleep deprivation
The UCSF scientists who identified the two known human genes that promote 'natural short sleep' -- nightly sleep that lasts just four to six hours but leaves people feeling well-rested -- have now discovered a third, and it's also the first gene that's ever been shown to prevent the memory deficits that normally accompany sleep deprivation.

Short sleep duration and sleep variability blunt weight loss
High sleep variability and short sleep duration are associated with difficulties in losing weight and body fat.

Nurses have an increased risk of sleep disorders and sleep deprivation
According to preliminary results of a new study, there is a high prevalence of insufficient sleep and symptoms of common sleep disorders among medical center nurses.

Common sleep myths compromise good sleep and health
People often say they can get by on five or fewer hours of sleep, that snoring is harmless, and that having a drink helps you to fall asleep.

Sleep tight! Researchers identify the beneficial role of sleep
Why do animals sleep? Why do humans 'waste' a third of their lives sleeping?

Does extra sleep on the weekends repay your sleep debt? No, researchers say
Insufficient sleep and untreated sleep disorders put people at increased risk for metabolic problems, including obesity and diabetes.

Read More: Sleep News and Sleep Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.